Next Article in Journal
Effects of Intramolecular Distance between Amyloidogenic Domains on Amyloid Aggregation
Next Article in Special Issue
Phosphoproteomics and Lung Cancer Research
Previous Article in Journal
Purification and Characterization of a Ginsenoside Rb1-Hydrolyzing β-Glucosidase from Aspergillus niger KCCM 11239
Previous Article in Special Issue
Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity
Review

Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer

1
Division of Surgical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA
2
Department of Surgery, University of Southern California, Los Angeles, CA 90001, USA
3
Division of Colorectal Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 11597, USA
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2012, 13(10), 12153-12168; https://doi.org/10.3390/ijms131012153
Received: 26 July 2012 / Revised: 6 September 2012 / Accepted: 6 September 2012 / Published: 25 September 2012
(This article belongs to the Special Issue Advances in Molecular Oncology (special issue))
The RAS gene family is among the most studied and best characterized of the known cancer-related genes. Of the three human ras isoforms, KRAS is the most frequently altered gene, with mutations occurring in 17%–25% of all cancers. In particular, approximately 30%–40% of colon cancers harbor a KRAS mutation. KRAS mutations in colon cancers have been associated with poorer survival and increased tumor aggressiveness. Additionally, KRAS mutations in colorectal cancer lead to resistance to select treatment strategies. In this review we examine the history of KRAS, its prognostic value in patients with colorectal cancer, and evidence supporting its predictive value in determining appropriate therapies for patients with colorectal cancer. View Full-Text
Keywords: KRAS; colorectal cancer; colon cancer; EGFR; Let7; ras; oncogenes KRAS; colorectal cancer; colon cancer; EGFR; Let7; ras; oncogenes
Show Figures

MDPI and ACS Style

Arrington, A.K.; Heinrich, E.L.; Lee, W.; Duldulao, M.; Patel, S.; Sanchez, J.; Garcia-Aguilar, J.; Kim, J. Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer. Int. J. Mol. Sci. 2012, 13, 12153-12168. https://doi.org/10.3390/ijms131012153

AMA Style

Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, Garcia-Aguilar J, Kim J. Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer. International Journal of Molecular Sciences. 2012; 13(10):12153-12168. https://doi.org/10.3390/ijms131012153

Chicago/Turabian Style

Arrington, Amanda K.; Heinrich, Eileen L.; Lee, Wendy; Duldulao, Marjun; Patel, Supriya; Sanchez, Julian; Garcia-Aguilar, Julio; Kim, Joseph. 2012. "Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer" Int. J. Mol. Sci. 13, no. 10: 12153-12168. https://doi.org/10.3390/ijms131012153

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop